Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHSE:600557) announces a share repurchase program. Under the program, the company will repurchase up to CNY 150 million worth of its shares. The shares will be repurchased at a price no more than CNY18 per share. The purpose of the program is to safeguard the company?s value and shareholders? rights and interests. The repurchased shares will be cancelled. The program will be funded from company's own funds. The program will be valid for a period of 3 months.

On April 25, 2024, the company announced that it adjusted the upper limit of the share repurchase price from CNY 18 per share to CNY 20 per share.